Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

April 7, 2023

Study Completion Date

April 7, 2023

Conditions

Solid Tumor

Interventions

DRUG

BAT6021

Ⅳ infusions

Trial Locations (3)

Guangdong Provincial People's Hospital, Guangzhou

The First Affiliated Hospital,Sun Yat-sen University, Guangzhou

The Affiliated Hospital of Guizhou Medical University, Guiyang